On Cancer: Clinical Trials

Share
Print
and/or
139 Blog posts found

In the Clinic

For MSK’s Gynecologic Oncologists, Uncommon Cancers Aren’t Always Rare

Learn about MSK’s expertise in treating vulvar and vaginal cancers, uterine sarcoma, uncommon ovarian cancers, and gestational trophoblastic disease.

Surgeon Mario Leitao in the operating room

Q & A

Meet Julia Glade Bender, Who’s Focused on Developing Better Treatments for Kids with Cancer

Pediatric oncologist Julia Glade Bender talks about the challenges of treating rare childhood cancers and how personalized medicine is leading to better therapies for tumors that are especially hard to treat.

Pediatric oncologist Julia Glade Bender

In The Clinic

FDA Approves Pexidartinib, a Targeted Therapy for a Tumor of the Joints

Pexidartinib is the first drug approved specifically to treat tenosynovial giant cell tumor.

Medical oncologist William Tap

In the Clinic

5 Reasons MSK Excels at Treating Gynecologic Cancers

Read why MSK’s medical team is the best in the nation at treating gynecologic cancers.

Memorial Sloan Kettering surgeons Oliver Zivanovic, Kara Long Roche, Ginger Gardner, and Yukio Sonoda

Roundup

Highlights from ASCO 2019: Progress in Treating Cancer in Children

MSK Kids doctors report advances in treating pediatric cancers at the 2019 meeting of the American Society of Clinical Oncology.

Crowd shot at ASCO 2019

Q & A

What Can Be Learned from a Negative Clinical Trial? Findings from a Sarcoma Study at ASCO 2019

At the ASCO meeting in Chicago, MSK medical oncologist William Tap talked about disappointing results from a new sarcoma drug, which didn’t increase survival.

Medical oncologist William Tap

In The Clinic

Prestigious Grant Bolsters Bladder Cancer Research at MSK

A prominent research grant will enable MSK doctors and scientists to advance the treatment of bladder cancer.

Conceptual orange-and-green-colored X-ray showing cancer of the bladder.

In the Clinic

Giving Drugs before Surgery Lowers the Risk of Prostate Cancer Returning

Giving a two-drug combination before prostate cancer surgery appears to reduce the chance that some high-risk forms of the disease will come back.

Memorial Sloan Kettering prostate cancer surgeon James Eastham with colleague.

Q & A

How MSK Is Reducing Inequality in Cancer Care in Harlem and Beyond

Medical Director Lewis Kampel discusses the mission and goals of the Ralph Lauren Center for Cancer Care.

Lewis Kampel speaks to a staff member